| Trial ID: | L0324 |
| Source ID: | NCT03669133
|
| Associated Drug: |
Vitamin E
|
| Title: |
Vitamin E for NASH Treatment in HIV Infected Individuals
|
| Acronym: |
--
|
| Status: |
Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
NAFLD|NASH - Nonalcoholic Steatohepatitis|HIV Infections
|
| Interventions: |
Drug: Vitamin E|Drug: Placebos
|
| Outcome Measures: |
Measure % change in liver fat content by magnetic resonance proton-density fat fraction|Determine the impact of vitamin E treatment on noninvasive markers of hepatic inflammation|Determine the impact of vitamin E treatment on noninvasive markers of systemic inflammation|Determine the impact of vitamin E treatment on noninvasive markers of hepatic fibrosis
|
| Sponsor/Collaborators: |
Indiana University School of Medicine|Indiana University
|
| Gender: |
All
|
| Age: |
18 Years to 75 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
56
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Triple (Participant, Care Provider, Investigator)|Primary Purpose: Treatment
|
| Start Date: |
December 1, 2019
|
| Completion Date: |
December 31, 2025
|
| Results First Posted: |
--
|
| Last Update Posted: |
January 26, 2022
|
| Locations: |
Indiana University School of Medicine, Indianapolis, Indiana, United States|Massachusetts General Hospital, Boston, Massachusetts, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT03669133
|
